Pharmacia to let companies make generic version of Rescriptor
BY Advocate.com Editors
February 05 2003 12:00 AM ET
Pharmacia Corp. announced last week that it will let generic-drug companies manufacture cheap copies of its HIV nonnucleoside reverse transcriptase inhibitor Rescriptor to sell in poor countries. The company plans to work with the International Dispensary Association in Amsterdam to provide licenses and technical skills to companies to make generic versions of the drug. IDA will monitor production quality and collect a 5% royalty to cover costs and fund new research, according to the plan. The generic copies would sell in 78 countries where annual per capita income is less than $1,200 or in those where the HIV infection rate is above 1%.
Even though the drug is not widely used in anti-HIV treatment, AIDS activists praised the idea of using a nonprofit agency as an intermediary. They stressed, however, that without billions of dollars more in aid from the West, the poorest countries will not be able to afford even the cheap generic copies of anti-HIV drugs.
- Holiday Guide: Shop Here, Not There
- WATCH: Jared Leto on Avoiding Trans Character 'Cliché' for 'Dallas Buyers Club'
- New Celeb Couple: Dustin Lance Black and Tom Daley
- Op-ed: Straight Teen Girls Can Change the World
- Bringing Diversity to the Digital Realm
- Making LGBT Spirits Bright This Holiday Season
- Travel Out Traveler Awards: Best Cruise Line? 24 min 45 sec ago
- Society Making LGBT Spirits Bright This Holiday Season 25 min 38 sec ago
- Women PHOTOS: Oxford University's Women's Rugby Club Bares All for Charity 41 min 26 sec ago
- Entertainment News Bill Hader Wanted Stefon's Goodbye to Be Emotional 4:50 PM
- Women 13 Reasons to Let AHS: Coven Cast A Spell on You -- in GIFs 4:36 PM
- Sports You Can Play and NFL Team Up With LGBT Youth 3:37 PM
- Entertainment News Gay Men's Chorus of Los Angeles Performs Parody of Joe Boxer Christmas Ad 3:36 PM